Search

everythinglearnresearchcommunity

for

Search:↓

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

Letrozole may help prevent seizures by reducing certain hormone levels.

Certain drugs may cause vitiligo, so patients should be monitored.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Regulatory measures are needed to ensure safe production and use of platelet concentrates in Brazil.

A man developed an allergic skin reaction to a rosacea treatment and improved after stopping the medication and receiving allergy-specific care.

Many patients on methotrexate experience significant side effects but still continue the medication.

Regulatory challenges make developing combination therapies in urology difficult and costly.

Blood pressure medications may increase the risk of skin cancer.

Ritlecitinib is safe and may effectively treat alopecia areata.

Pharmacists play a key role in health education and managing treatments for conditions like hair loss and smoking cessation.

The document gives treatment advice for various skin conditions, like using metronidazole for perioral dermatitis and minoxidil for hair loss.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Finasteride is commonly used for male pattern hair loss but has potential risks, including irreversible sexual dysfunction.

The study found that combining different databases gives a better estimate of drug side effects in hospitals.

The document concludes that "Dictamnus" has a rich cultural history and potential as a herbal medicine, warranting more research into its effects and safety.

Baricitinib may effectively treat oral lichen planus.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

PRP may help short-term with ankle arthritis pain, but long-term effects are unclear.

Patients with one autoimmune disease should be checked for other autoimmune disorders.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Smoking and certain health conditions like thyroid disease may make palmoplantar pustulosis harder to treat.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

The Unani Pharmacopoeia-Based Formulation significantly improved symptoms of enlarged prostate in rats.

People need more education on the safe and proper use of dietary supplements.